ArticleOncogene2017

DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.

D W Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.